JAMP REPAGLINIDE
Identification of Jamp Repaglinide
| No description |
Google image searchProduct monograph
Active ingredient
repaglinide, 0.5 MG
DIN: 02354926
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 07-MAR-2023
ATC:
- A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
- A10B — BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS (ATC, ATC/DDD)
- A10BX — Other blood glucose lowering drugs, excl. insulins (ATC, ATC/DDD)
- A10BX02 — REPAGLINIDE (ATC/DDD)
Reference brand drug: Gluconorm
Pharmaceutical standard: MFR
